Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02355314Completed
Open-label, single-arm trial, sponsored by CHU Saint-Etienne. Primary endpoint: Doppler-based renal resistive index at Day 0. Started Dec 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02355314.